Goldman Sachs’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $168K | Sell |
|
|||||
|
2023
Q4 | $370K | Buy |
|
|||||
|
2023
Q3 | $111K | Sell |
|
|||||
|
2023
Q2 | $482K | Sell |
|
|||||
|
2023
Q1 | $1.37M | Buy |
|
|||||
|
2022
Q4 | $439K | Sell |
|
|||||
|
2022
Q3 | $2.39M | Sell |
|
|||||
|
2022
Q2 | $2.66M | Buy |
|
|||||
|
2022
Q1 | $767K | Buy |
|
|||||
|
2021
Q4 | $1.01M | Sell |
|
|||||
|
2021
Q3 | $2.18M | Buy |
|
|||||
|
2021
Q2 | $354K | Sell |
|
|||||
|
2021
Q1 | $554K | Sell |
|
|||||
|
2020
Q4 | $2.4M | Buy |
|